首页 > 最新文献

Clinical Medicine Insights- Pathology最新文献

英文 中文
A Colonic Perineurioma. 结肠膜周围瘤。
Q3 Medicine Pub Date : 2018-12-06 eCollection Date: 2018-01-01 DOI: 10.1177/1179555718815918
Tomoyuki Otani, Kinta Hatakeyama, Emi Ohtani, Susumu Nakayama, Takashi Fujimoto, Chiho Ohbayashi

Perineurioma is a mesenchymal neoplasm best known in soft-tissue pathology. A colonic perineurioma is a relatively recently described entity and sometimes encountered in specimens from the large intestine, especially distal colon. Without its recognition, a perineurioma can be misdiagnosed as other more common gastrointestinal spindle cell neoplasms. Here, we describe a case of colonic perineurioma with polypoid growth extruding into the intestinal lumen. Case. A woman in her seventh decade of life underwent a follow-up colonoscopy after an uneventful resection of a benign colonic polyp. A previously undetected 6-mm polyp was found in the sigmoid colon and was resected endoscopically. Microscopic examination of the lesion revealed a proliferation of bland spindle cells in the lamina propria mucosae, which were immunohistochemically positive for epithelial membrane antigen, claudin 1, and glucose transporter-1. A colonic perineurioma was diagnosed.

会膜瘤是一种在软组织病理学中最为人所知的间充质肿瘤。结肠骨膜瘤是最近才发现的一种肿瘤,有时在大肠,尤其是远端结肠的标本中发现。如果未被识别,会被误诊为其他更常见的胃肠道梭形细胞肿瘤。我们在此报告一例息肉样生长于肠腔内的结肠膜瘤。的情况。一位70岁的妇女在顺利切除良性结肠息肉后接受了结肠镜检查。在乙状结肠发现了一个以前未被发现的6毫米息肉,并在内镜下切除。显微镜检查显示,病变固有粘膜内无色素梭形细胞增生,上皮膜抗原、克audin -1和葡萄糖转运蛋白-1免疫组化阳性。诊断为结肠膜瘤。
{"title":"A Colonic Perineurioma.","authors":"Tomoyuki Otani,&nbsp;Kinta Hatakeyama,&nbsp;Emi Ohtani,&nbsp;Susumu Nakayama,&nbsp;Takashi Fujimoto,&nbsp;Chiho Ohbayashi","doi":"10.1177/1179555718815918","DOIUrl":"https://doi.org/10.1177/1179555718815918","url":null,"abstract":"<p><p>Perineurioma is a mesenchymal neoplasm best known in soft-tissue pathology. A colonic perineurioma is a relatively recently described entity and sometimes encountered in specimens from the large intestine, especially distal colon. Without its recognition, a perineurioma can be misdiagnosed as other more common gastrointestinal spindle cell neoplasms. Here, we describe a case of colonic perineurioma with polypoid growth extruding into the intestinal lumen. <i>Case.</i> A woman in her seventh decade of life underwent a follow-up colonoscopy after an uneventful resection of a benign colonic polyp. A previously undetected 6-mm polyp was found in the sigmoid colon and was resected endoscopically. Microscopic examination of the lesion revealed a proliferation of bland spindle cells in the lamina propria mucosae, which were immunohistochemically positive for epithelial membrane antigen, claudin 1, and glucose transporter-1. A colonic perineurioma was diagnosed.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-12-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179555718815918","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36847456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features. 鞘内甲氨蝶呤诱导坏死性脊髓病:1例报告及组织学特征回顾。
Q3 Medicine Pub Date : 2018-11-04 eCollection Date: 2018-01-01 DOI: 10.1177/1179555718809071
Hamza Tariq, Andrea Gilbert, Francis E Sharkey

Central nervous system (CNS) relapse of acute lymphoblastic leukemia (ALL) is associated with a poor prognosis. However, prophylactic measures, including intrathecal (IT) methotrexate, reduce the incidence of CNS relapse in these patients considerably. Unfortunately, IT methotrexate can cause several neurologic complications, including transverse myelopathy; ie, the development of isolated spinal cord dysfunction over hours or days following the IT infusion of methotrexate, but in the absence of a compressive lesion. Transverse myelopathy following IT methotrexate is a well-established clinical phenomenon, but the histologic features have been described only very rarely. We report the autopsy findings from a 31-year-old man with a history of T-cell ALL who received prophylactic IT methotrexate in anticipation of a bone marrow transplant. Microscopic examination showed transverse necrosis of the thoracic cord, with massive infiltration by macrophages and lymphocytes, and perivascular lymphocytic infiltrates. There was cavitary necrosis of cervical and lumbar spinal cord involving the entire gray matter and focal white matter, as well as extensive subpial vacuolar degeneration of the dorsal and lateral columns.

急性淋巴细胞白血病(ALL)的中枢神经系统(CNS)复发与不良预后相关。然而,包括鞘内注射(IT)甲氨蝶呤在内的预防措施,可显著降低这些患者中枢神经系统复发的发生率。不幸的是,甲氨蝶呤可引起多种神经系统并发症,包括横贯脊髓病;即,在静脉输注甲氨蝶呤后数小时或数天内出现孤立性脊髓功能障碍,但没有压缩性损伤。甲氨蝶呤后的横断性脊髓病是一种公认的临床现象,但组织学特征很少被描述。我们报告了一名31岁的有t细胞ALL病史的男性的尸检结果,他在骨髓移植前接受了预防性的甲氨蝶呤。镜下示胸椎横断坏死,巨噬细胞和淋巴细胞大量浸润,血管周围淋巴细胞浸润。颈、腰椎脊髓出现空洞性坏死,累及整个灰质和局灶性白质,脊背和侧柱出现广泛的枕下空泡变性。
{"title":"Intrathecal Methotrexate-Induced Necrotizing Myelopathy: A Case Report and Review of Histologic Features.","authors":"Hamza Tariq,&nbsp;Andrea Gilbert,&nbsp;Francis E Sharkey","doi":"10.1177/1179555718809071","DOIUrl":"https://doi.org/10.1177/1179555718809071","url":null,"abstract":"<p><p>Central nervous system (CNS) relapse of acute lymphoblastic leukemia (ALL) is associated with a poor prognosis. However, prophylactic measures, including intrathecal (IT) methotrexate, reduce the incidence of CNS relapse in these patients considerably. Unfortunately, IT methotrexate can cause several neurologic complications, including transverse myelopathy; ie, the development of isolated spinal cord dysfunction over hours or days following the IT infusion of methotrexate, but in the absence of a compressive lesion. Transverse myelopathy following IT methotrexate is a well-established clinical phenomenon, but the histologic features have been described only very rarely. We report the autopsy findings from a 31-year-old man with a history of T-cell ALL who received prophylactic IT methotrexate in anticipation of a bone marrow transplant. Microscopic examination showed transverse necrosis of the thoracic cord, with massive infiltration by macrophages and lymphocytes, and perivascular lymphocytic infiltrates. There was cavitary necrosis of cervical and lumbar spinal cord involving the entire gray matter and focal white matter, as well as extensive subpial vacuolar degeneration of the dorsal and lateral columns.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179555718809071","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36693699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Autopsy Patients With Obesity or Metabolic Syndrome as Basic Cause of Death: Are There Pathological Differences Between These Groups? 以肥胖或代谢综合征为基本死因的尸检患者:这两组之间有病理差异吗?
Q3 Medicine Pub Date : 2018-07-30 eCollection Date: 2018-01-01 DOI: 10.1177/1179555718791575
Lucas Braz Gonçalves, Helio Amante Miot, Maria Aparecida Custódio Domingues, Cristiano Claudino Oliveira

Background: The objectives of this study were the evaluation of pathological characteristics of patients with obesity or metabolic syndrome (MS) as basic cause of death, associating the autopsy findings with some clinical aspects and the abdominal adipose panicle thickness.

Methods: A total of 88 autopsy cases were studied, divided into 2 groups based on the main cause of death: group 1 (n = 15) obesity and group 2 (n = 73) MS. Clinical summaries of autopsy requests, macroscopic findings, and histologic sections were reviewed.

Results: The definition of obesity as the basic cause of death is associated with larger thickness of the abdominal adipose panicle, being 8.5 cm (P = .001) the best measurement, according to the receiver operating characteristic curve. Hypertensive cardiopathy (P = .001), ischemic cardiopathy (P = .003), coronary (P = .008)/systemic (P = .005) atherosclerosis, and arterial (P = .014)/arteriolar (P = .027) nephrosclerosis are associated with the diagnosis of MS. Steatohepatitis is associated with the diagnosis of obesity (P = .030); however, its association with the thickness of the abdominal adipose panicle is not statistically significant (P = .211).

Conclusions: In the context of an obese patient in autopsy, pathologist may use the information about abdominal adipose panicle associated with heart, kidney, and liver findings, even macroscopic ones, to decide the basic cause death between obesity and MS.

背景:本研究的目的是评估肥胖或代谢综合征(MS)患者作为基本死亡原因的病理特征,将尸检结果与一些临床方面和腹部脂肪穗厚度联系起来。方法:对88例尸检病例进行分析,根据主要死因分为2组:1组(n = 15)肥胖,2组(n = 73) ms。回顾尸检要求、宏观表现和组织学切片的临床总结。结果:根据受试者工作特征曲线,肥胖与腹部脂肪穗厚度较大相关,以8.5 cm (P = 0.001)为最佳测量值。高血压心脏病(P = .001)、缺血性心脏病(P = .003)、冠状动脉(P = .008)/全身(P = .005)动脉粥样硬化(P = .014)/小动脉(P = .027)肾硬化与ms诊断相关;然而,其与腹部脂肪圆锥花序厚度的相关性无统计学意义(P = 0.211)。结论:在肥胖患者尸检的背景下,病理学家可以利用腹部脂肪穗与心脏、肾脏和肝脏相关的信息,甚至是宏观的发现,来确定肥胖与MS之间的基本死因。
{"title":"Autopsy Patients With Obesity or Metabolic Syndrome as Basic Cause of Death: Are There Pathological Differences Between These Groups?","authors":"Lucas Braz Gonçalves,&nbsp;Helio Amante Miot,&nbsp;Maria Aparecida Custódio Domingues,&nbsp;Cristiano Claudino Oliveira","doi":"10.1177/1179555718791575","DOIUrl":"https://doi.org/10.1177/1179555718791575","url":null,"abstract":"<p><strong>Background: </strong>The objectives of this study were the evaluation of pathological characteristics of patients with obesity or metabolic syndrome (MS) as basic cause of death, associating the autopsy findings with some clinical aspects and the abdominal adipose panicle thickness.</p><p><strong>Methods: </strong>A total of 88 autopsy cases were studied, divided into 2 groups based on the main cause of death: group 1 (n = 15) obesity and group 2 (n = 73) MS. Clinical summaries of autopsy requests, macroscopic findings, and histologic sections were reviewed.</p><p><strong>Results: </strong>The definition of obesity as the basic cause of death is associated with larger thickness of the abdominal adipose panicle, being 8.5 cm (<i>P</i> = .001) the best measurement, according to the receiver operating characteristic curve. Hypertensive cardiopathy (<i>P</i> = .001), ischemic cardiopathy (<i>P</i> = .003), coronary (<i>P</i> = .008)/systemic (<i>P</i> = .005) atherosclerosis, and arterial (<i>P</i> = .014)/arteriolar (<i>P</i> = .027) nephrosclerosis are associated with the diagnosis of MS. Steatohepatitis is associated with the diagnosis of obesity (<i>P</i> = .030); however, its association with the thickness of the abdominal adipose panicle is not statistically significant (<i>P</i> = .211).</p><p><strong>Conclusions: </strong>In the context of an obese patient in autopsy, pathologist may use the information about abdominal adipose panicle associated with heart, kidney, and liver findings, even macroscopic ones, to decide the basic cause death between obesity and MS.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-07-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179555718791575","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"36377017","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Tubular Adenoma of the Breast: A Clinicopathologic Study of a Series of 9 Cases. 乳腺管状腺瘤:9例临床病理分析。
Q3 Medicine Pub Date : 2018-02-05 eCollection Date: 2018-01-01 DOI: 10.1177/1179555718757499
Boubacar Efared, Ibrahim S Sidibé, Souley Abdoulaziz, Nawal Hammas, Laila Chbani, Hinde El Fatemi

Tubular adenoma of the breast is one of the most rare benign neoplasms, accounting for only 0.13% to 1.7% of all breast benign tumors. Little is known about this rare neoplasm as the current literature offers only some case reports or a few number of small series. The aim of our study is to provide some clinicopathologic features of the breast tubular adenoma. We retrospectively analyzed at our department of pathology all cases of breast tubular adenomas confirmed by immunohistochemistry over a period of 9 years (2009-2017). Nine cases of breast tubular adenoma have been recorded, with an average age of 31.44 years. Five tumors were located at the right side (55.55%), and most cases had suspicious aspects on imaging techniques (6 cases out of 9). The diagnosis has been made on 5 resected specimens (lumpectomy) and on 4 core needle biopsies. The tumor size ranged from 0.9 to 7 cm (mean size of 3.08 cm) and had well-circumscribed margins with elastic consistency. The histopathologic analysis showed a typical pattern of proliferating round and uniform tubules lined by regular epithelial cells surrounded by myoepithelial cells, packed in a small amount of stroma, highlighted by CD34 immunostaining. Tubular adenoma is a rare breast benign neoplasm of young premenopausal women. The radiologic aspects are often worrisome and only the histopathologic analysis can achieve the correct definitive diagnosis by excluding all potential differential diagnoses.

乳腺管状腺瘤是最罕见的良性肿瘤之一,仅占乳腺良性肿瘤的0.13% ~ 1.7%。目前对这种罕见的肿瘤知之甚少,因为目前的文献只提供了一些病例报告或少量的小系列。我们研究的目的是提供乳腺管状腺瘤的一些临床病理特征。我们回顾性分析了9年来(2009-2017年)所有经免疫组织化学证实的乳腺管状腺瘤病例。本文报告乳腺管状腺瘤9例,平均年龄31.44岁。5例肿瘤位于右侧(55.55%),多数影像学表现可疑(9例中有6例)。5例切除标本(乳房肿瘤切除术)和4例核心穿刺活检确诊。肿瘤大小为0.9 ~ 7cm(平均3.08 cm),边界清晰,有弹性一致性。组织病理学分析显示典型的增生圆形和均匀的小管,由规则上皮细胞排列,被肌上皮细胞包围,包裹在少量间质中,CD34免疫染色突出显示。管状腺瘤是一种罕见的乳腺良性肿瘤,多发于年轻绝经前妇女。放射学方面往往令人担忧,只有组织病理学分析才能通过排除所有潜在的鉴别诊断获得正确的明确诊断。
{"title":"Tubular Adenoma of the Breast: A Clinicopathologic Study of a Series of 9 Cases.","authors":"Boubacar Efared,&nbsp;Ibrahim S Sidibé,&nbsp;Souley Abdoulaziz,&nbsp;Nawal Hammas,&nbsp;Laila Chbani,&nbsp;Hinde El Fatemi","doi":"10.1177/1179555718757499","DOIUrl":"https://doi.org/10.1177/1179555718757499","url":null,"abstract":"<p><p>Tubular adenoma of the breast is one of the most rare benign neoplasms, accounting for only 0.13% to 1.7% of all breast benign tumors. Little is known about this rare neoplasm as the current literature offers only some case reports or a few number of small series. The aim of our study is to provide some clinicopathologic features of the breast tubular adenoma. We retrospectively analyzed at our department of pathology all cases of breast tubular adenomas confirmed by immunohistochemistry over a period of 9 years (2009-2017). Nine cases of breast tubular adenoma have been recorded, with an average age of 31.44 years. Five tumors were located at the right side (55.55%), and most cases had suspicious aspects on imaging techniques (6 cases out of 9). The diagnosis has been made on 5 resected specimens (lumpectomy) and on 4 core needle biopsies. The tumor size ranged from 0.9 to 7 cm (mean size of 3.08 cm) and had well-circumscribed margins with elastic consistency. The histopathologic analysis showed a typical pattern of proliferating round and uniform tubules lined by regular epithelial cells surrounded by myoepithelial cells, packed in a small amount of stroma, highlighted by CD34 immunostaining. Tubular adenoma is a rare breast benign neoplasm of young premenopausal women. The radiologic aspects are often worrisome and only the histopathologic analysis can achieve the correct definitive diagnosis by excluding all potential differential diagnoses.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2018-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179555718757499","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35836102","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 15
Effects of Prolonged Treatment With Co-trimoxazole on the Thyroid Gland, Liver, and Epididymal Sperm Reserve in Dogs. 长期服用共三唑对狗甲状腺、肝脏和附睾精子储备的影响
Q3 Medicine Pub Date : 2017-12-07 eCollection Date: 2017-01-01 DOI: 10.1177/1179555717742881
Davinson C Anyogu, Vincent So Shoyinka, John I Ihedioha

Co-trimoxazole is an antimicrobial drug gotten from potentiation of sulfamethoxazole with trimethoprim. It is widely used for the treatment of bacterial and protozoan infections in humans. It is also used in veterinary clinics against susceptible microorganisms, but thyroid dysfunction has raised concern especially in dogs. This study aimed to determine the effects of prolonged treatment with co-trimoxazole in euthyroid dogs. Dogs were given co-trimoxazole at 30, 60, and 120 mg/kg body weight at 12-hour intervals for 21 days. Standard procedures were used to assay total T4 and T3, thyrotropin, testosterone, aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase in serum. The thyroid gland and testes were weighed. In addition, thyroid and liver were examined histologically. Epididymal sperm count was also performed. Co-trimoxazole caused dose-dependent depression of serum thyroxine levels with severe colloid depletion, intrafollicular hemorrhage, hyperplasia, and hypertrophy of the follicular cells. The liver showed vacuolar hepatopathy. Epididymal sperm count was low in the 120 mg/kg-treated group. The study revealed that thyroid hemorrhage and lowered epididymal sperm reserve were new findings in co-trimoxazole toxicity in dogs.

共三唑是一种抗菌药物,由磺胺甲噁唑与三甲氧苄氨嘧啶增效而成。它被广泛用于治疗人类的细菌和原生动物感染。但甲状腺功能障碍引起了人们的关注,尤其是在狗身上。本研究旨在确定甲状腺功能正常的狗长期服用共三唑的影响。连续 21 天以每公斤体重 30、60 和 120 毫克的剂量,每隔 12 小时给狗注射一次联合三唑。采用标准程序检测血清中的总 T4 和 T3、促甲状腺激素、睾酮、天冬氨酸氨基转移酶、丙氨酸氨基转移酶和碱性磷酸酶。对甲状腺和睾丸进行了称重。此外,还对甲状腺和肝脏进行了组织学检查。还进行了附睾精子计数。共三唑会导致血清甲状腺素水平呈剂量依赖性降低,并伴有严重的胶体耗竭、卵泡内出血、卵泡细胞增生和肥大。肝脏出现空泡性肝炎。120 毫克/千克剂量组的附睾精子数量较低。该研究表明,甲状腺出血和附睾精子储备量降低是犬共同三唑类药物毒性的新发现。
{"title":"Effects of Prolonged Treatment With Co-trimoxazole on the Thyroid Gland, Liver, and Epididymal Sperm Reserve in Dogs.","authors":"Davinson C Anyogu, Vincent So Shoyinka, John I Ihedioha","doi":"10.1177/1179555717742881","DOIUrl":"10.1177/1179555717742881","url":null,"abstract":"<p><p>Co-trimoxazole is an antimicrobial drug gotten from potentiation of sulfamethoxazole with trimethoprim. It is widely used for the treatment of bacterial and protozoan infections in humans. It is also used in veterinary clinics against susceptible microorganisms, but thyroid dysfunction has raised concern especially in dogs. This study aimed to determine the effects of prolonged treatment with co-trimoxazole in euthyroid dogs. Dogs were given co-trimoxazole at 30, 60, and 120 mg/kg body weight at 12-hour intervals for 21 days. Standard procedures were used to assay total T<sub>4</sub> and T<sub>3</sub>, thyrotropin, testosterone, aspartate aminotransferase, alanine aminotransferase, and alkaline phosphatase in serum. The thyroid gland and testes were weighed. In addition, thyroid and liver were examined histologically. Epididymal sperm count was also performed. Co-trimoxazole caused dose-dependent depression of serum thyroxine levels with severe colloid depletion, intrafollicular hemorrhage, hyperplasia, and hypertrophy of the follicular cells. The liver showed vacuolar hepatopathy. Epididymal sperm count was low in the 120 mg/kg-treated group. The study revealed that thyroid hemorrhage and lowered epididymal sperm reserve were new findings in co-trimoxazole toxicity in dogs.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/1f/0d/10.1177_1179555717742881.PMC5724629.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35657584","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site. CCAAT/增强子结合蛋白转录起始位点下游的功能研究。
Q3 Medicine Pub Date : 2017-11-15 eCollection Date: 2017-01-01 DOI: 10.1177/1179555717694556
Yujie Liu, Michael R Nonnemacher, Aikaterini Alexaki, Vanessa Pirrone, Anupam Banerjee, Luna Li, Evelyn Kilareski, Brian Wigdahl

Previous studies have identified a CCAAT/enhancer binding protein (C/EBP) site located downstream of the transcriptional start site (DS3). The role of the DS3 element with respect to HIV-1 transactivation by Tat and viral replication has not been characterized. We have demonstrated that DS3 was a functional C/EBPβ binding site and mutation of this site to the C/EBP knockout DS3-9C variant showed lower HIV-1 long terminal repeat (LTR) transactivation by C/EBPβ. However, it was able to exhibit similar or even higher transcription levels by Tat compared to the parental LTR. C/EBPβ and Tat together further enhanced the transcription level of the parental LAI-LTR and DS3-9C LTR, with higher levels in the DS3-9C LTR. HIV molecular clone viruses carrying the DS3-9C variant LTR demonstrated a decreased replication capacity and delayed rate of replication. These results suggest that DS3 plays a role in virus transcriptional initiation and provides new insight into C/EBP regulation of HIV-1.

先前的研究已经确定了位于转录起始位点(DS3)下游的CCAAT/增强子结合蛋白(C/EBP)位点。DS3元件在HIV-1被Tat转录激活和病毒复制中的作用尚未被描述。我们已经证明DS3是一个功能性的C/EBPβ结合位点,并且该位点突变为C/EBP敲除的DS3- 9c变体,显示C/EBPβ降低了HIV-1长末端重复(LTR)的转激活。C/EBPβ和Tat共同作用,进一步提高了亲本LAI-LTR和DS3-9C LTR的转录水平,其中DS3-9C LTR的转录水平更高,携带DS3-9C LTR变体的HIV分子克隆病毒表现出复制能力下降和复制速率延迟。这些结果表明DS3在病毒转录起始中起作用,并为C/EBP调控HIV-1提供了新的思路。
{"title":"Functional Studies of CCAAT/Enhancer Binding Protein Site Located Downstream of the Transcriptional Start Site.","authors":"Yujie Liu,&nbsp;Michael R Nonnemacher,&nbsp;Aikaterini Alexaki,&nbsp;Vanessa Pirrone,&nbsp;Anupam Banerjee,&nbsp;Luna Li,&nbsp;Evelyn Kilareski,&nbsp;Brian Wigdahl","doi":"10.1177/1179555717694556","DOIUrl":"https://doi.org/10.1177/1179555717694556","url":null,"abstract":"<p><p>Previous studies have identified a CCAAT/enhancer binding protein (C/EBP) site located downstream of the transcriptional start site (DS3). The role of the DS3 element with respect to HIV-1 transactivation by Tat and viral replication has not been characterized. We have demonstrated that DS3 was a functional C/EBPβ binding site and mutation of this site to the C/EBP knockout DS3-9C variant showed lower HIV-1 long terminal repeat (LTR) transactivation by C/EBPβ. However, it was able to exhibit similar or even higher transcription levels by Tat compared to the parental LTR. C/EBPβ and Tat together further enhanced the transcription level of the parental LAI-LTR and DS3-9C LTR, with higher levels in the DS3-9C LTR. HIV molecular clone viruses carrying the DS3-9C variant LTR demonstrated a decreased replication capacity and delayed rate of replication. These results suggest that DS3 plays a role in virus transcriptional initiation and provides new insight into C/EBP regulation of HIV-1.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179555717694556","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35273332","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Impact of Pathology Review for Decision Therapy in Localized Prostate Cancer. 病理综述对局限性前列腺癌决策治疗的影响。
Q3 Medicine Pub Date : 2017-11-02 eCollection Date: 2017-01-01 DOI: 10.1177/1179555717740130
Pedro Luiz Serrano Usón, Ricardo Silvestre E Silva Macarenco, Fernando Nunes Oliveira, Oren Smaletz

Background: The Gleason score is an essential tool in the decision to treat localized prostate cancer. However, experienced pathologists can classify Gleason score differently than do low-volume pathologists, and this may affect the treatment decision. This study sought to assess the impact of pathology review of external biopsy specimens from 23 men with a recent diagnosis of localized prostate cancer.

Methods: All external biopsy specimens were reviewed at our pathology department. Data were retrospectively collected from scanned charts.

Results: The median patient age was 63 years (range: 46-74 years). All patients had a Karnofsky performance score of 90% to 100%. The median prostate-specific antigen level was 23.6 ng/dL (range: 1.04-13.6 ng/dL). Among the 23 reviews, the Gleason score changed for 8 (35%) patients: 7 upgraded and 1 downgraded. The new Gleason score affected the treatment decision in 5 of 8 cases (62.5%).

Conclusions: This study demonstrates the need for pathology review in patients with localized prostate cancer before treatment because Gleason score can change in more than one-third of patients and can affect treatment decision in almost two-thirds of recategorized patients.

背景:Gleason评分是决定治疗局限性前列腺癌的重要工具。然而,经验丰富的病理学家对Gleason评分的分类与低容量病理学家不同,这可能会影响治疗决策。本研究旨在评估最近诊断为局限性前列腺癌的23名男性的外部活检标本的病理审查的影响。方法:所有外部活检标本均在我院病理科复查。回顾性地从扫描图表中收集数据。结果:患者中位年龄为63岁(范围:46-74岁)。所有患者的Karnofsky表现评分为90%至100%。前列腺特异性抗原中位数为23.6 ng/dL(范围:1.04 ~ 13.6 ng/dL)。在23篇综述中,8例(35%)患者的Gleason评分发生变化:7例升级,1例降级。新Gleason评分影响了8例患者中5例(62.5%)的治疗决策。结论:本研究表明,有必要在治疗前对局限性前列腺癌患者进行病理检查,因为超过三分之一的患者Gleason评分会发生变化,并影响近三分之二重新分类患者的治疗决策。
{"title":"Impact of Pathology Review for Decision Therapy in Localized Prostate Cancer.","authors":"Pedro Luiz Serrano Usón,&nbsp;Ricardo Silvestre E Silva Macarenco,&nbsp;Fernando Nunes Oliveira,&nbsp;Oren Smaletz","doi":"10.1177/1179555717740130","DOIUrl":"https://doi.org/10.1177/1179555717740130","url":null,"abstract":"<p><strong>Background: </strong>The Gleason score is an essential tool in the decision to treat localized prostate cancer. However, experienced pathologists can classify Gleason score differently than do low-volume pathologists, and this may affect the treatment decision. This study sought to assess the impact of pathology review of external biopsy specimens from 23 men with a recent diagnosis of localized prostate cancer.</p><p><strong>Methods: </strong>All external biopsy specimens were reviewed at our pathology department. Data were retrospectively collected from scanned charts.</p><p><strong>Results: </strong>The median patient age was 63 years (range: 46-74 years). All patients had a Karnofsky performance score of 90% to 100%. The median prostate-specific antigen level was 23.6 ng/dL (range: 1.04-13.6 ng/dL). Among the 23 reviews, the Gleason score changed for 8 (35%) patients: 7 upgraded and 1 downgraded. The new Gleason score affected the treatment decision in 5 of 8 cases (62.5%).</p><p><strong>Conclusions: </strong>This study demonstrates the need for pathology review in patients with localized prostate cancer before treatment because Gleason score can change in more than one-third of patients and can affect treatment decision in almost two-thirds of recategorized patients.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179555717740130","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35560713","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Prognostic Impact of Extracapsular Lymph Node Invasion and Myofibroblastic Activity in Extrahepatic Bile Duct Cancer. 肝外胆管癌包膜外淋巴结浸润和肌成纤维细胞活性对预后的影响。
Q3 Medicine Pub Date : 2017-09-06 eCollection Date: 2017-01-01 DOI: 10.1177/1179555717729652
Tadashi Yoshizawa, Keinosuke Ishido, Kensuke Saito, Toshihiro Haga, Hiroko Seino, Yunyan Wu, Satoko Morohashi, Kenichi Hakamada, Hiroshi Kijima

Extrahepatic bile duct carcinoma is a potentially malignant gastrointestinal lesion. Cancer cells spread via the lymphatic system to regional lymph nodes and help in tumor progression. However, there are no reports on the prognostic impact of extracapsular lymph node invasion and myofibroblastic activity in this cancer. Hence, we classified the histopathologic patterns of lymph nodes into 2 patterns: extracapsular lymph node invasion or not. Based on this, we investigated 32 cases of extrahepatic bile duct cancer with lymph node metastasis and classified 21 cases as positive and 11 cases as negative. The extracapsular lymph node invasion cases were associated with poor disease-free survival and overall survival. The myofibroblast density of the metastatic foci was significantly higher in the extracapsular lymph node invasion cases. This is the first study to demonstrate that extracapsular lymph node invasion cases were associated with poor prognosis and that the myofibroblast distribution contributed to malignancy.

肝外胆管癌是一种潜在的胃肠道恶性病变。癌细胞通过淋巴系统扩散到局部淋巴结,促进肿瘤进展。然而,尚无关于这种癌症的囊外淋巴结浸润和肌成纤维细胞活性对预后影响的报道。因此,我们将淋巴结的组织病理类型分为两种类型:囊外淋巴结浸润和未浸润。在此基础上,我们分析了32例肝外胆管癌伴淋巴结转移的病例,其中阳性21例,阴性11例。囊外淋巴结浸润病例与较差的无病生存期和总生存期相关。在囊外淋巴结浸润的病例中,转移灶的肌成纤维细胞密度明显较高。这是第一个证明囊外淋巴结浸润病例与不良预后相关的研究,并且肌成纤维细胞的分布有助于恶性肿瘤。
{"title":"Prognostic Impact of Extracapsular Lymph Node Invasion and Myofibroblastic Activity in Extrahepatic Bile Duct Cancer.","authors":"Tadashi Yoshizawa,&nbsp;Keinosuke Ishido,&nbsp;Kensuke Saito,&nbsp;Toshihiro Haga,&nbsp;Hiroko Seino,&nbsp;Yunyan Wu,&nbsp;Satoko Morohashi,&nbsp;Kenichi Hakamada,&nbsp;Hiroshi Kijima","doi":"10.1177/1179555717729652","DOIUrl":"https://doi.org/10.1177/1179555717729652","url":null,"abstract":"<p><p>Extrahepatic bile duct carcinoma is a potentially malignant gastrointestinal lesion. Cancer cells spread via the lymphatic system to regional lymph nodes and help in tumor progression. However, there are no reports on the prognostic impact of extracapsular lymph node invasion and myofibroblastic activity in this cancer. Hence, we classified the histopathologic patterns of lymph nodes into 2 patterns: extracapsular lymph node invasion or not. Based on this, we investigated 32 cases of extrahepatic bile duct cancer with lymph node metastasis and classified 21 cases as positive and 11 cases as negative. The extracapsular lymph node invasion cases were associated with poor disease-free survival and overall survival. The myofibroblast density of the metastatic foci was significantly higher in the extracapsular lymph node invasion cases. This is the first study to demonstrate that extracapsular lymph node invasion cases were associated with poor prognosis and that the myofibroblast distribution contributed to malignancy.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-09-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179555717729652","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35354664","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Pulmonary Cryptococcosis Presenting With Lung Mass: Report of 7 Cases and Review of Literature. 以肺肿块为表现的肺隐球菌病:附7例报告并文献复习。
Q3 Medicine Pub Date : 2017-08-04 eCollection Date: 2017-01-01 DOI: 10.1177/1179555717722962
Kanet Kanjanapradit, Zdravko Kosjerina, Wiwatana Tanomkiat, Warangkana Keeratichananont, Siripen Panthuwong

Pulmonary cryptococcosis is commonly found in immunocompromised patients. This microorganism rarely infects immunocompetent individuals, and when it does, it causes mild symptoms. The radiological findings of this disease may involve an intrapulmonary mass that mimics lung tumor. The objective of this study was to review the clinicopathological information, radiological findings, and treatment of patients who presented with intrapulmonary mass due to cryptococcosis. This study collected data from 7 patients who were treated at Songklanagarind Hospital, Songkhla, Thailand, between 2009 and 2014. Their clinical data, radiological findings, pathological results, and treatment protocols were reviewed. The patients were 2 women and 5 men, ranging in age from 37 to 79 years old. One case was an immunocompromised host. Four cases experienced the chest symptoms of dyspnea, hemoptysis, and chronic cough. The most common location of mass was the left lower lobe (71%). Four cases had a history of bird contact. Lung lobectomy was performed in 3 cases (42%), and all of the patients were treated with oral fluconazole. An intrapulmonary mass caused by this microorganism is mainly found in immunocompetent patients. Treatment with the antifungal drug fluconazole is very effective.

肺隐球菌病常见于免疫功能低下的患者。这种微生物很少感染免疫正常的个体,即使感染,也会引起轻微的症状。这种疾病的影像学表现可能包括肺内肿块,类似于肺肿瘤。本研究的目的是回顾因隐球菌病而出现肺内肿块的患者的临床病理信息、放射学表现和治疗。本研究收集了2009年至2014年间在泰国宋卡的Songklanagarind医院接受治疗的7名患者的数据。我们回顾了他们的临床资料、影像学表现、病理结果和治疗方案。患者女2例,男5例,年龄37 ~ 79岁。1例为免疫功能低下的宿主。4例出现呼吸困难、咯血、慢性咳嗽等胸部症状。最常见的肿块位置是左下叶(71%)。4例有禽类接触史。3例(42%)行肺叶切除术,所有患者均口服氟康唑治疗。由这种微生物引起的肺内肿块主要见于免疫功能正常的患者。用抗真菌药物氟康唑治疗非常有效。
{"title":"Pulmonary Cryptococcosis Presenting With Lung Mass: Report of 7 Cases and Review of Literature.","authors":"Kanet Kanjanapradit,&nbsp;Zdravko Kosjerina,&nbsp;Wiwatana Tanomkiat,&nbsp;Warangkana Keeratichananont,&nbsp;Siripen Panthuwong","doi":"10.1177/1179555717722962","DOIUrl":"https://doi.org/10.1177/1179555717722962","url":null,"abstract":"<p><p>Pulmonary cryptococcosis is commonly found in immunocompromised patients. This microorganism rarely infects immunocompetent individuals, and when it does, it causes mild symptoms. The radiological findings of this disease may involve an intrapulmonary mass that mimics lung tumor. The objective of this study was to review the clinicopathological information, radiological findings, and treatment of patients who presented with intrapulmonary mass due to cryptococcosis. This study collected data from 7 patients who were treated at Songklanagarind Hospital, Songkhla, Thailand, between 2009 and 2014. Their clinical data, radiological findings, pathological results, and treatment protocols were reviewed. The patients were 2 women and 5 men, ranging in age from 37 to 79 years old. One case was an immunocompromised host. Four cases experienced the chest symptoms of dyspnea, hemoptysis, and chronic cough. The most common location of mass was the left lower lobe (71%). Four cases had a history of bird contact. Lung lobectomy was performed in 3 cases (42%), and all of the patients were treated with oral fluconazole. An intrapulmonary mass caused by this microorganism is mainly found in immunocompetent patients. Treatment with the antifungal drug fluconazole is very effective.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-08-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179555717722962","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35329146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 14
Is Tolerance Broken in Autoimmunity? 自身免疫是否破坏了耐受性?
Q3 Medicine Pub Date : 2017-05-16 eCollection Date: 2017-01-01 DOI: 10.1177/1179555717712716
Dama Laxminarayana

Autoimmune diseases are classified into about 80 different types based on their specificity related to system, organ and/or tissue. About 5% of the western population is affected by this anomaly, but its worldwide incidence is unknown. Autoimmune diseases are heterogeneous in nature and clinical manifestations range from benign disorders to life-threatening conditions. Autoimmunity strikes at any stage of life, but age and/or gender also play role in onset of some of these anomalies. The autoimmune pathogenesis is initiated by the origination of autoantigens, which leads to the development of autoantibodies followed by auto-immunogenicity and the ultimate onset of autoimmunity. There is a lack of suitable therapies to treat autoimmune diseases, because mechanisms involved in the onset of these anomalies were poorly understood. Present therapies are limited to symptomatic treatment and come with severe side effects. Here, I described the molecular mechanisms and cellular events involved in the initiation of autoimmunity and proposed better strategies to modulate such molecular and cellular anomalies, which will help in preventing and/or controlling autoimmune pathogenesis and ultimately aid in enhancing the quality of life.

自身免疫性疾病根据其与系统、器官和/或组织的特异性可分为约80种不同类型。大约5%的西方人口受到这种异常的影响,但其全球发病率尚不清楚。自身免疫性疾病本质上是异质性的,临床表现从良性疾病到危及生命的疾病不等。自身免疫可以在生命的任何阶段发生,但年龄和/或性别也在这些异常的发病中起作用。自身免疫发病机制是由自身抗原的产生引起自身抗体的产生,进而产生自身免疫原性,最终发生自身免疫。缺乏合适的治疗自身免疫性疾病的方法,因为涉及这些异常发病的机制尚不清楚。目前的治疗方法仅限于对症治疗,并且有严重的副作用。在这里,我描述了参与自身免疫启动的分子机制和细胞事件,并提出了更好的策略来调节这种分子和细胞异常,这将有助于预防和/或控制自身免疫发病机制,最终有助于提高生活质量。
{"title":"Is Tolerance Broken in Autoimmunity?","authors":"Dama Laxminarayana","doi":"10.1177/1179555717712716","DOIUrl":"10.1177/1179555717712716","url":null,"abstract":"<p><p>Autoimmune diseases are classified into about 80 different types based on their specificity related to system, organ and/or tissue. About 5% of the western population is affected by this anomaly, but its worldwide incidence is unknown. Autoimmune diseases are heterogeneous in nature and clinical manifestations range from benign disorders to life-threatening conditions. Autoimmunity strikes at any stage of life, but age and/or gender also play role in onset of some of these anomalies. The autoimmune pathogenesis is initiated by the origination of autoantigens, which leads to the development of autoantibodies followed by auto-immunogenicity and the ultimate onset of autoimmunity. There is a lack of suitable therapies to treat autoimmune diseases, because mechanisms involved in the onset of these anomalies were poorly understood. Present therapies are limited to symptomatic treatment and come with severe side effects. Here, I described the molecular mechanisms and cellular events involved in the initiation of autoimmunity and proposed better strategies to modulate such molecular and cellular anomalies, which will help in preventing and/or controlling autoimmune pathogenesis and ultimately aid in enhancing the quality of life.</p>","PeriodicalId":43543,"journal":{"name":"Clinical Medicine Insights- Pathology","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2017-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1179555717712716","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"35058612","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Clinical Medicine Insights- Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1